drospirenone and ethinyl estradiol combination has been researched along with Thromboembolism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shapiro, S | 1 |
Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
Lenzer, J | 1 |
Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
1 review(s) available for drospirenone and ethinyl estradiol combination and Thromboembolism
Article | Year |
---|---|
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
3 other study(ies) available for drospirenone and ethinyl estradiol combination and Thromboembolism
Article | Year |
---|---|
Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases.
Topics: Androstenes; Bias; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Data Interpretation, Statistical; Databases, Factual; Ethinyl Estradiol; Female; Humans; Risk Factors; Thromboembolism; Venous Thromboembolism | 2013 |
US panel rules that warnings on two birth control pills be strengthened.
Topics: Adverse Drug Reaction Reporting Systems; Advisory Committees; Androstenes; Contraceptives, Oral; Drug Industry; Drug Labeling; Ethinyl Estradiol; Female; Humans; Thromboembolism; United States; United States Food and Drug Administration | 2011 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |